BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3217275)

  • 1. Oncogene expression in prostate cancer: Dunning R3327 rat dorsal prostatic adenocarcinoma system.
    Cooke DB; Quarmby VE; Mickey DD; Isaacs JT; French FS
    Prostate; 1988; 13(4):263-72. PubMed ID: 3217275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of ras proto-oncogenes in the Dunning R3327 rat prostatic adenocarcinoma system.
    Cooke DB; Quarmby VE; Petrusz P; Mickey DD; Der CJ; Isaacs JT; French FS
    Prostate; 1988; 13(4):273-87. PubMed ID: 3064050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of gonadotropin-releasing hormone receptor mRNA in the rat ventral prostate and dunning R3327 PAP adenocarcinoma before and after castration.
    Tieva A; Wilkström P; Olofsson JI; Bergh A; Damber JE
    Prostate; 1999 May; 39(2):101-7. PubMed ID: 10221565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ expression of mRNA for proto-oncogenes in benign prostatic hyperplasia and in prostatic carcinoma.
    Funa K; Nordgren H; Nilsson S
    Scand J Urol Nephrol; 1991; 25(2):95-100. PubMed ID: 1714628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of gonadotropin-releasing hormone receptor expression with the progression of prostate cancer in the Dunning rat adenocarcinoma sublines.
    Tieva A; Bergh A; Damber JE
    Acta Oncol; 2005; 44(3):299-303. PubMed ID: 16076703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth-related elevations of DNA topoisomerase II levels found in Dunning R3327 rat prostatic adenocarcinomas.
    Nelson WG; Cho KR; Hsiang YH; Liu LF; Coffey DS
    Cancer Res; 1987 Jun; 47(12):3246-50. PubMed ID: 3034406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
    Brändström A; Westin P; Bergh A; Cajander S; Damber JE
    Cancer Res; 1994 Jul; 54(13):3594-601. PubMed ID: 8012987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and localization of androgen receptor in the R-3327 Dunning rat prostatic adenocarcinoma.
    Quarmby VE; Beckman WC; Cooke DB; Lubahn DB; Joseph DR; Wilson EM; French FS
    Cancer Res; 1990 Feb; 50(3):735-9. PubMed ID: 2404576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of protein kinase C isozyme messenger RNAs in dunning R-3327 rat prostatic tumors.
    Powell CT; Fair WR; Heston WD
    Cell Growth Differ; 1994 Feb; 5(2):143-9. PubMed ID: 8180127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of transforming growth factor-beta 1 in rat ventral prostate and Dunning R3327 PAP prostate tumor after castration and estrogen treatment.
    Lindström P; Bergh A; Holm I; Damber JE
    Prostate; 1996 Oct; 29(4):209-18. PubMed ID: 8876704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of prolactin in modulating the effects of tamoxifen on growth of the Dunning R3327 rat prostate adenocarcinoma.
    Sylvester PW; Ip MM
    Prostate; 1987; 10(1):57-67. PubMed ID: 3822918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different pattern of expression of cellular oncogenes in human non-small-cell lung cancer cell lines.
    Kiefer PE; Wegmann B; Bacher M; Erbil C; Heidtmann H; Havemann K
    J Cancer Res Clin Oncol; 1990; 116(1):29-37. PubMed ID: 1690210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric analysis of R3327 rat prostate adenocarcinoma grown in vivo and in vitro.
    Claflin AJ; Pollack A; Malinin T; Block NL; Irvin GL
    J Natl Cancer Inst; 1982 Jul; 69(1):79-87. PubMed ID: 6954325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of a transfected v-Harvey-ras oncogene in a Dunning rat prostate adenocarcinoma and the development of high metastatic ability.
    Treiger B; Isaacs J
    J Urol; 1988 Dec; 140(6):1580-6. PubMed ID: 3057238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced expression of the c-myc protooncogene in high-grade human prostate cancers.
    Buttyan R; Sawczuk IS; Benson MC; Siegal JD; Olsson CA
    Prostate; 1987; 11(4):327-37. PubMed ID: 2446300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arguments against the prostatic origin of the R-3327 Dunning H tumor.
    Goebel HW; Rausch U; Steinhoff M; Seitz J; Bacher M; Papotti M; Bussolati G; Tuohimaa P; Aumüller G
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(1):9-18. PubMed ID: 1352078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polarographic needle electrode measurements of oxygen in rat prostate carcinomas: accuracy and reproducibility.
    Yeh KA; Biade S; Lanciano RM; Brown DQ; Fenning MC; Babb JS; Hanks GE; Chapman DC
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):111-8. PubMed ID: 7642408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cellular oncogenes in human prostatic carcinoma cell lines.
    Rijnders AW; van der Korput JA; van Steenbrugge GJ; Romijn JC; Trapman J
    Biochem Biophys Res Commun; 1985 Oct; 132(2):548-54. PubMed ID: 3904752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncodevelopmental enzymes of the Dunning rat prostatic adenocarcinoma.
    Hall M; Silverman L; Wenger AS; Mickey DD
    Cancer Res; 1985 Sep; 45(9):4053-9. PubMed ID: 2992772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of prolactin on rat dorsolateral prostate and R3327 prostatic tumor sublines.
    Johnson MP; Thompson SA; Lubaroff DM
    J Urol; 1985 Jun; 133(6):1112-20. PubMed ID: 4039764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.